University Of Erlangen-nürnberg Medical School

This study tested whether adding radiation to the immunotherapy drug pembrolizumab could help control metastatic head and neck cancer that had already been treated once. It was designed for adults with at least two tumors, one of which would receive radiation. The trial was termi…